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FUNDING STEM CELL RESEARCH: THE 
CONVERGENCE OF SCIENCE, RELIGION & POLITICS 
IN THE FORMATION OF PUBLIC HEALTH POLICY 
Edward A. Fallone* 
Public health policy in the United States has long been 
influenced by three factors: the imperfect and evolving state of 
scientific knowledge about human biology, the far less 
changeable status of religious doctrine concerning the human 
body, and the constant compromises and accommodations made 
by elected officials in an attempt to garner the support of 
divergent political interest groups. Scholars have even 
developed a new term to describe this field of inquiry: ‚public 
bioethics.‛1 The current debate over the funding of stem cell 
research, in particular human embryonic stem cell (hESC) 
research, is but the most recent convergence of these three 
influences on public policy. Advocates of federal and state 
government funding of embryonic stem cell research argue that 
our democratic government should foster and promote the path 
of discovery, especially where that inquiry focuses on the causes 
and cures of disease.  Opponents of federal and state funding 
argue that our democratic government should reflect the moral 
values of our population, a portion of which object to embryonic 
 
* Associate Professor, Marquette University Law School.  In my private 
life, I am the president of a nonprofit organization that advocates in 
support of all forms of stem cell research.  I would like to thank 
Professor Aaron D. Levine for his comments and suggestions.  I would 
also like to thank my daughter Emma and my son Andrew, both of 
whom inspire me every day.  
 1.  O. Carter Snead, Science, Public Bioethics, and the Problem of Integration, 43 
U.C. DAVIS L. REV. 1529, 1532 (2010) (defining ‚public bioethics‛ as the ‚the 
governance of the practice of medicine, biotechnology, and biomedical research in 
the name of ethical goods‛).    
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stem cell research on religious grounds.2 
Differing conceptions of knowledge contribute to this 
debate.  Scientific knowledge follows an uncertain path, and 
those who are engaged in scientific research assume that 
complete and final knowledge is an unattainable goal.3  New 
discoveries are episodic and tentative. While impressive 
additions to the universe of human knowledge have been made 
since 1998, when Dr. Jamie Thomson successfully isolated 
human embryonic stem cells for the first time,4 today there still 
remains much that we do not understand about cell biology. 
Religious doctrine, in contrast, rests upon the assertion that 
certain truths are unassailable and are not subject to change 
regardless of the results of scientific inquiry.5  The doctrines of 
the Catholic Church, in particular, historically have opposed 
both contraception and abortion.  These doctrines are based 
upon Church teachings in regards to human sexuality and 
reproduction that have evolved little since the time of Saint 
Augustine.6 
Some observers assert that it is inevitable for scientific and 
 
 2.  An October 2010 Harris Interactive poll found strong support for 
embryonic stem cell research among the public.  According to the poll, 73% of 
respondents support stem cell research "as long as the parents of the embryo give 
their permission, and the embryo would otherwise be destroyed."  Among the 
poll’s findings: 58% of Republicans support stem cell research (with 24% of 
Republicans opposed), while the research is supported by 69% of Catholics and 58% 
of born-again Christians.  In contrast, the poll found that embryonic stem cell 
research is opposed by 16% of Catholics and 22% of born-again Christians.  See 
Amanda Gardner, Most Americans Back Embryonic Stem Cell Research: Poll, 
BLOOMBERG BUSINESSWEEK (Oct. 7, 2010), http://www.businessweek.com/lifestyle 
/content/healthday/644026.html. 
 3.  BERTRAND RUSSELL, RELIGION AND SCIENCE 14 (Oxford University Press 
1997) (1935). 
 4.  James A. Thomson et al., Embryonic Stem Cell Lines Derived from Human 
Blastocysts, 282 SCIENCE 1145, 1145 (1998). 
 5.  See RUSSELL, supra note 3, at 13-17. 
 6.  See generally JOHN T. NOONAN, JR., CONTRACEPTION: A HISTORY OF ITS 
TREATMENT BY THE CATHOLIC THEOLOGIANS AND CANONISTS (1965).  There is, 
however, a vigorous debate concerning the extent to which Catholic doctrine on 
these matters has in fact changed in meaningful ways over the centuries.  See 
generally Christine E. Gudorf, Contraception and Abortion in Roman Catholicism, in 
SACRED RIGHTS: THE CASE FOR CONTRACEPTION AND ABORTION IN WORLD 
RELIGIONS 55 (Daniel C. Maguire ed., 2003).    
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religious viewpoints to come into direct conflict.7  Others believe 
that it is possible for the government to craft policies that 
advance both scientific and religious perspectives.8  Indeed, the 
very concept of public bioethics as a field of inquiry assumes 
that it is both necessary and possible for government 
policymakers to accommodate these two differing attitudes 
towards the acquisition of knowledge.9 
The convergence of science, religion and politics in the 
health care context has engendered controversy in the past.  In 
the 1980s, a newly identified communicable disease known as 
Acquired Immune Deficiency Syndrome (AIDS) gave rise to 
fears of an epidemic and prompted calls for a public health 
response.  Medical researchers criticized the federal government 
for being slow to develop and adopt a national AIDS strategy.  
In addition, many scientists questioned Congress’ decision to 
fund research for a vaccine through supplemental 
appropriations rather than by increases to the budget of the 
National Institutes of Health (NIH).10 
The early (and incomplete) scientific understanding of the 
disease led some persons to conclude that the illness was 
primarily spread through immoral conduct.  Other segments of 
the public objected to using tax dollars to fund public education 
and prevention programs that advocated the use of condoms.  
 
 7.  See RUSSELL, supra note 3, at 13-17. 
 8.  See GARRY WILLS, HEAD AND HEART: A HISTORY OF CHRISTIANITY IN 
AMERICA 547-52 (2007). 
 9.  See Snead, supra note 1, at 1602 (concluding that the question of federally 
funding embryonic stem cell research ‚should be decided by politically accountable 
public officials, applying the humanistic concepts of moral reasoning‛).  
 10.  Much of the controversy over the appropriate role of the federal 
government in responding to the AIDS crisis played out as a funding debate: 
From June 1981 to June 1982, a period generally considered to be the first 
twelve months of the epidemic, the Centers for Disease Control and 
Prevention (CDC) spent $1 million on AIDS, compared with $9 million in 
response to the much smaller problem of Legionnaires’ disease.  In late 
1982, Congress allocated $2.6 million to be targeted for the CDC’s AIDS 
research, but the Reagan administration claimed that the CDC did not 
need the money and opposed any congressional supplemental 
appropriations designed to fund federal governmental AIDS policy efforts. 
ENCYCLOPEDIA OF AIDS: A SOCIAL, POLITICAL, CULTURAL, AND SCIENTIFIC RECORD 
OF THE HIV EPIDEMIC 164 (Raymond A. Smith, ed., Penguin Reference 2001) (1998).     
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Meanwhile, on the other end of the political spectrum, gay rights 
advocates objected to the utilization of traditional public health 
powers, such as quarantine, as a means of combating the spread 
of AIDS.  Liberal groups feared that these ‚archaic‛ police 
powers would inevitably be used to target homosexuals in 
general rather than the affected population.11  As a result, the 
public health response to the AIDS crisis was hampered by the 
need to accommodate religious and political interest groups. 
The funding of medical research12 using stem cells provides 
a contemporary opportunity to examine the intersection of 
science, religion and politics in the formation of public health 
policy.  In Section I, this article reviews the science of stem cell 
research.  Section II addresses religious and ethical perspectives 
relating to stem cell research.  In Section III, the current funding 
landscape for stem cell research is examined.  Interest group 
litigation seeking to influence federal and state funding policies 
is discussed in Section IV.  Finally, in Section V, this article 
articulates two neutral principles that should guide 
policymakers in future situations where public health decisions 
implicate science, religion and politics. 
 THE SCIENCE OF STEM CELL RESEARCH 
 A BRIEF HISTORY OF REGENERATIVE MEDICINE 
Researchers and their advocates believe that stem cell 
research has the potential to greatly alleviate human suffering.  
 
 11.  See generally Edward A. Fallone, Preserving the Public Health: A Proposal to 
Quarantine Recalcitrant AIDS Carriers, 68 B.U. L. REV. 441 (1988).  
 12.  Medical research takes place in three stages.  Basic medical research 
(sometimes called the ‚discovery phase‛) typically takes place at academic 
institutions and is usually funded by the state and federal governments rather than 
by for-profit corporations.  Preclinical research, the second stage, focuses on 
applications that build off of basic research discoveries and on ‚proof of concept‛ 
testing.  Academic institutions engage in this second stage of research, along with 
biotech and pharmaceutical companies seeking to develop patentable technologies.  
The third stage of medical research is clinical research.  Clinical research is 
performed in order to verify the safety and efficacy of treatments on human 
patients, and it is typically conducted by both academic institutions and by large 
corporations developing a marketable product.     
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Numerous diseases and chronic medical conditions, including 
Diabetes, ALS, Multiple Sclerosis, Parkinson’s Disease, 
Alzheimer’s, and spinal cord injury, may be susceptible to 
treatment or even cures using stem cells.  Many of these diseases 
disproportionately affect the elderly, an important factor in 
consideration of the rapidly aging American population.13  
Supporters argue that the development of therapies for chronic 
health conditions would also be beneficial to the economy, 
because costs associated with the treatment of chronic disease 
are a significant contributor to the steady rise in health care 
spending in our nation.  However, stem cell research is merely 
the latest stage in the long and often controversial history of 
regenerative medicine.14 
For hundreds of years, medical research has sought 
treatments for human tissue and organs that have been 
damaged, whether by accident, genetic defect, or degenerative 
disease.15 One consistent focus of this research has been the 
possibility of replacing the non-functioning body part with a 
healthy alternative. The earliest blood transfusions in the 
eighteenth century became the template for the first organ 
transplants – the replacement of damaged or diseased organs 
with healthy organs from a donor. As the transplantation 
techniques advanced over the decades, transplants involving 
kidneys, hearts, lungs and other types of organs have become 
commonplace. 
One drawback to organ transplantation is the need to 
suppress the recipient’s immune system in order to prevent the 
rejection of foreign tissue.  However, a far more significant 
drawback has proven to be the limited supply of donated organs 
 
 13.  See Cynthia M. A. Geppert, Stem Cell Research, in ENCYCLOPEDIA OF AGING 
AND PUBLIC HEALTH 760, 760-61  (Sana Loue & Martha Sajatovic eds., 2008) (‚Stem 
cell research offers enormous potential to improve the quality of life of older people 
and even to extend the life span.‛). 
 14.  The term ‚regenerative medicine‛ applies to treatments intended to repair 
damaged or diseased tissues and organs in the human body, whether via tissue 
engineering, stem cell therapy, the use of mechanical devices or other techniques. 
 15.  ‚Tissue‛ refers to specialized human cells that perform a specific bodily 
function.  ‚Organs‛ refer to body parts containing multiple related types of tissue. 
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for transplantation. In response to this shortage, researchers 
have explored the use of mechanical devices that function as 
artificial organs and, in certain instances, the use of organs 
obtained from animal sources. These developments led to 
objections by some to the introduction of non-human material 
into the recipient’s body, on religious grounds.  Nonetheless, a 
majority of the public favored the use of these alternative 
sources of organs so long as ethical guidelines were followed.16  
Neither mechanical nor animal organs are an exact 
substitute for the healthy human organs that they are designed 
to replace, however.  In addition, despite recent advances in 
nanotechnology, researchers still struggle to create machines 
that can perform biological functions at a cellular level.  
Therefore, the finite supply of donated human organs continues 
to be the primary limitation on the use of transplantation as a 
treatment for disease and chronic injury. 
In the 1970s, significant progress was made in the field of 
recombinant DNA.  Researchers inserted strands of human 
DNA into bacteria in order to manufacture proteins and artificial 
hormones that exactly mimic their parallels in the human body.  
An entire new branch of the pharmaceutical industry developed 
in order to produce drugs designed to trigger natural responses 
within the patient’s body.17  These advances in recombinant 
DNA were initially controversial, and some persons viewed the 
combination of human DNA with a bacterial host as evidence of 
a scientific community run amuck.18  
 
 16.  For a discussion of religious perspectives on the bodily incorporation of 
mechanical devices, see generally Courtney S. Campbell et al., The Bodily 
Incorporation of Mechanical Devices: Ethical and Religious Issues (Part 2), 16 CAMBRIDGE 
Q. HEALTHCARE ETHICS 268 (2007). 
 17.  For example, diabetics today inject artificial insulin that is genetically 
identical to human insulin.  The patient must still inject the artificial insulin several 
times a day, so it is not the equivalent of replacing the patient’s damaged pancreas.  
Nonetheless, the genetically manufactured insulin is considered superior to insulin 
harvested from slaughtered pigs, which was the previous source of injectable 
insulin.  Similarly, drugs created using recombinant DNA can be used to trigger an 
increase in the body’s red blood cell production during chemotherapy. 
 18.  See ROGER SHATTUCK, FORBIDDEN KNOWLEDGE: FROM PROMETHEUS TO 
PORNOGRAPHY 186-195 (1996). 
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Stem cell research is the most recent stage in the historical 
progress of regenerative medicine.  Stem cell research focuses on 
the process of human biology at a cellular level, and is therefore 
one way that researchers hope to learn how to repair or replace 
human organs and tissues.  The ultimate goal of this science is to 
create new adult human cells, either by growing them from 
undifferentiated stem cell lines or by transforming one type of 
adult cell directly into another type.  One potential use of these 
newly created cells is to test experimental drugs on human 
tissue without having to conduct clinical trials on human 
subjects.  However, a second potential use, which is of particular 
interest to millions of Americans with chronic medical 
conditions, is to create a new source of organs and tissues that 
can be used for transplantation. 
 STEM CELL RESEARCH: A VARIETY OF APPROACHES 
Stem cells are ‚unspecialized‛ cells that can generate 
healthy new cells, tissues, and organs.  They are the master cells 
of the human body and, when isolated outside of the body, they 
can be manipulated to transform into more specialized cells that 
perform specific bodily functions.  A stem cell ‚line‛ is formed 
by extracting stem cells from their source and placing them in a 
growth culture in a petri dish.  The stem cells are then induced 
to self-replicate, generating a colony of stem cells that 
continually replaces itself.  Researchers then apply factors to the 
stem cell line that cause the stem cells to transform into 
specialized adult cells. 
 Adult Stem Cell Research 
After birth, small amounts of stem cells remain in many 
mature human organs, where they continue to create specialized 
cells that replace cells that have become damaged or worn out.  
Researchers have long known that it is possible to use these 
adult stem cells in order to generate different types of 
specialized replacement cells.  Adult stem cells are characterized 
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as ‚multipotent,‛19 meaning that they can be transformed into a 
limited number of specialized cell types.  Replacement cells 
created using adult stem cells are usually closely related to the 
types of cells that reside in the tissue where the adult stem cells 
were located.  In other words, adult stem cells derived from 
blood-producing bone marrow can be used to produce different 
kinds of specialized blood cells, but it is unclear whether they 
can be used to produce nerve or muscle cells. 
Embryonic Stem Cell Research 
After the union of sperm and egg, the fertilized egg 
undergoes several stages of development.  The fertilized egg 
divides into two cells, then four, eight, and so forth, until it 
reaches a stage where it is called a morula (‚berry‛ in Latin).20  
Approximately four days after fertilization, this solid mass of 
cells begins to transform from a compressed morula into a 
hollowed-out ball called a blastocyst.21  The blastocyst is about 
the size of the period at the end of this sentence, and its interior 
contains a thin ridge of cells.22  These are the embryonic stem 
cells, and they can be extracted from the blastocyst and grown in 
culture.  Embryonic stem cells are the progenitor cells that serve 
as precursors of every cell type that will later be necessary for 
human development. 
Prior to extraction from the blastocyst, the embryonic stem 
cells are ‚totipotent,‛ meaning that they possess the ability to 
develop into any of the three types of human tissue (endoderm, 
mesoderm, or ectoderm) and also to develop into the placental 
tissues needed for the blastocyst to implant in the uterus.23  An 
embryonic stem cell line is created by removing the embryonic 
stem cells from the blastocyst and inducing them to reproduce in 
 
 19.  See Ralph Dittman, Latest Developments in Stem Cell Research, THE 
HUFFINGTON POST (Nov. 21, 2007, 6:10 PM), http://www.huffingtonpost.com/ralph-
dittman/latest-developments-in-st_b_73783.html?view=screen.   
 20.  Id. 
      21.  Id.  
      22.  Id.  
      23.  Id. 
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a cultured petri dish.  Once removed from the blastocyst, the 
embryonic stem cells are ‚pluripotent,‛ meaning that they have 
the ability to develop into any of the 210 or so different cell types 
of a human body24 but that they no longer possess the ability to 
form placental tissues. 
The extraction of the embryonic stem cells from the 
blastocyst typically occurs between five and ten days after 
fertilization.25 Extraction is performed during this early time 
frame because, as the blastocyst continues to develop, the cells 
become even more differentiated and specialized.  Until about 
day fourteen, the cell mass could be divided in two segments, 
and it would result in two viable identical cell masses.  
However, after day fourteen the cells become differentiated to 
the point that, if one were to attempt to divide them, the entire 
cell mass would arrest and stop developing.  In addition, by day 
fourteen the cells have become so specialized that they cease to 
be pluripotent, but are merely multipotent instead.26 
Self-perpetuating embryonic stem cell lines were first 
successfully isolated from humans and cultured by Dr. James 
Thomson at the University of Wisconsin in 1998.27  In the United 
States, hESC research uses eggs that have been fertilized in vitro 
and then donated for research purposes with the informed 
consent of their donors.  These eggs were not fertilized in a 
woman’s body, but rather were created at an in vitro fertility 
clinic.  They exist because the in vitro fertilization (IVF) process 
 
      24.  Id. 
   25.  Extraction of the stem cells from the blastocyst collapses the outer line of 
cells and renders the blastocyst incapable of implantation in the uterine wall.  It is 
the destruction of the blastocyst at this stage that has engendered opposition to 
hESC research.  It should be noted that at this stage in the development of the 
blastocyst, were it located in the human body, it would still be traveling through 
the fallopian tubes and would not yet have reached the uterus.  It is estimated that 
fewer than one third of fertilized eggs successfully implant in the uterus during 
human reproduction and proceed to develop to term.  Instead, the majority of eggs 
that are fertilized within the woman’s body pass through the uterus or, after 
implantation, spontaneously abort.  Biologists do not consider conception to occur 
until implantation in the womb.  See HAROLD J. MOROWITZ & JAMES S. TREFIL, THE 
FACTS OF LIFE: SCIENCE AND THE ABORTION CONTROVERSY 51 (1992).   
     26.     See Dittman, supra note 19. 
     27.     See Thomson et al., supra note 4, at 1145. 
FALLONE 5/24/2011  4:04 PM 
256 MARQUETTE ELDER’S ADVISOR [Vol. 12 
typically results in the creation of excess blastocysts, and if not 
used for research purposes the majority of these fertilized eggs 
would be destroyed.28 Federal funding of hESC research is 
currently limited to research using excess blastocysts obtained 
from IVF clinics.  In addition, federal dollars may only be used 
to support research using pre-existing hESC lines and not for the 
derivation of new hESC lines from blastocysts. 
 Induced Pluripotent Stem Cells (iPS cells) 
In November 2007, both Dr. James Thomson of the 
University of Wisconsin and a separate team under the direction 
of Dr. Shinya Yamanaka in Japan announced that they had 
discovered how to create cells that behave like embryonic stem 
cells by adding a ‚cocktail‛ of four gene transcription factors to 
an adult skin cell.29  This technique converts routine body cells, 
or somatic cells, into pluripotent stem cells.  In technical terms, 
the technique ‚de-differentiates‛ the adult cell.  These re-
programmed somatic cells are called ‚induced pluripotent stem 
cells‛ or iPS cells. 
The breakthrough involved using four factors — including 
cancer genes — that were inserted into human adult skin cells 
using retroviruses as a vehicle.  These factors ‚re-programmed‛ 
the skin cells with the result that they began to behave like 
embryonic stem cells.  These iPS cells appear to have a plasticity 
similar to embryonic stem cells, although it is unknown whether 
they are an exact equivalent.  One potential advantage of using 
stem cells created via the iPS technique is that there would be no 
immune system issues should those cells be transplanted back 
into the patient that donated the skin cells.  Early concerns 
expressed over the use of cancer genes and retroviruses to do the 
 
 28.  A 2004 study found that eighty-four percent of fertility clinics routinely 
destroyed unused blastocysts created for implantation.  See Andrea D. Gurmankin 
et al., Embryo Disposal Practices in IVF Clinics in the United States, 22 POL. & LIFE SCI. 
4, 6 (2004) (In a survey, 175 out of 208 IVF clinics reported that they had policies 
permitting the disposal of excess embryos.).       
 29.  See Kazutoshi Takahashi et al., Induction of Pluripotent Stem Cells from Adult 
Human Fibroblasts by Defined Factors, 131 CELL 861, 868 (2007). 
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reprogramming — the introduction of which might ‚switch on‛ 
cancer genes already present within the body — were addressed 
through the development of new methods of re-programming 
which do not utilize cancer genes. 
 Direct Cell Re-Programming 
The expanded knowledge of cell biology that has been 
gained from stem cell research has also led to techniques that 
transform one type of specialized adult cell directly into another 
type of adult cell.  Using this approach, researchers can side-step 
the entire process of creating any stem cell lines.  This process 
has been labeled ‚direct reprogramming.‛ 
In 2008, Dr. Douglas Melton at the Harvard Stem Cell 
Institute announced successful experiments in mice where he 
transformed normal pancreas cells into more specialized insulin 
producing cells.30  He achieved these results by using a 
‚cocktail‛ of three transcription factors to transform one type of 
adult mouse cell directly into a different type of adult cell.  This 
advance allowed the creation of new adult mouse cells without 
first creating a stem cell line.  If this technique can be replicated 
using human cells, it would also seem to avoid potential 
problems with the extraction of adult stem cells or the rejection 
of transplanted cells by the immune system.  Similar to iPS 
research, the initial direct re-programming results involved the 
use of a virus as the vehicle for introducing the genes into the 
cells.  A non-viral approach needs to be developed to avoid the 
risk that the virus will induce the growth of cancerous tumors. 
Comparability and Equivalency Among Different Types of Stem 
Cell Research 
Because human embryonic stem cells are able to 
differentiate into any cell type in the body, scientists believe that 
they hold great promise – both as a source of replacement cells 
 
 30.  See Qiao Zhou et al., In Vivo Reprogramming of Adult Pancreatic Exocrine Cells 
to β-Cells, 455 NATURE 627, 630-31 (2008). 
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for transplantation and for use in testing drug interactions in 
human tissue. Their plasticity, and their durability as self-
sustaining cell lines that self-replicate over long periods of time, 
are the primary advantages of embryonic stem cells. For 
example, researchers have used embryonic stem cells to create 
large quantities of red blood cells, raising the prospect that one 
day blood drives may be unnecessary.31  In addition, because 
embryonic stem cells have developed only once from their 
embryonic state, tissue created using embryonic stem cells is 
considered to be the closest equivalent to naturally occurring 
human tissue.  Immunosuppression issues remain one of the 
primary concerns in regards to hESC research. 
In contrast, adult stem cells extracted from the patient’s 
own body do not trigger an immune system response when 
used to create specialized cells that are re-introduced into the 
patient’s body. However, there are currently several 
disadvantages associated with the use of adult stem cells.  First, 
researchers have yet to find a collection of adult stem cells 
throughout the body that can give rise to all of the various types 
of cells and tissues present in the human body.  In addition, in 
some instances adult stem cells may be present in mature organs 
but the extraction of these adult stem cells is difficult or 
dangerous to the patient.  This is currently the case with adult 
stem cells located in the heart and the brain. 
Second, adult stem cells are often present in only minute 
quantities in mature tissues in the body.32  They can therefore be 
difficult to isolate, purify and replicate in large quantities.  This 
is an important drawback, as large numbers of cells are likely to 
be necessary for stem cell replacement therapies.  In contrast, 
hESC derived cells are relatively easy to grow in cultures and 
can multiply perfectly for long periods of time. 
Finally, it is still unclear whether adult stem cells contain 
 
 31.  See Shi-Jiang Lu et al., Biologic Properties and Enucleation of Red Blood Cells 
from Human Embryonic Stem Cells, 112 BLOOD 4475, 4475 (2008). 
 32.  Stem Cell Information Frequently Asked Questions, NAT’L INSTS. HEALTH, 
http://stemcells.nih.gov/info/faqs.asp (last updated Aug. 2, 2010).  
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more DNA abnormalities than hESC cells.  It is thought that 
‚sunlight, toxins, or errors in making more DNA copies during 
the course of a [cell’s] lifetime‛ may increase the incidence of 
abnormalities among adult stem cells.33  While researchers may 
eventually overcome some or all of the above limitations, adult 
stem cells cannot currently be considered a complete substitute 
for embryonic stem cells. 
There are also uncertainties associated with the derivation 
of iPS cell lines.  For example, there is evidence that iPS cell lines 
are less efficient than embryonic stem cell lines in self-
replicating, and that the tissue developed using iPS cell lines 
differs in noticeable ways from tissue derived from hESC lines.34  
In addition, the process of reversing an adult cell to its 
embryonic state creates not only iPS cells but also non-iPS cell 
colonies and ‚pseudo-iPS cells‛ that fail to regress completely.35  
Therefore, it can be challenging for researchers to differentiate 
among iPS cells sharing the same petri dish with potentially 
cancerous cells. Scientists need to continue to work on the 
purification techniques necessary to identify and isolate the true 
iPS cells. There also remains considerable uncertainty 
concerning the stability of iPS cells over time.  Some researchers 
believe that the re-programming process renders iPS cells less 
stable than embryonic stem cells, and there are indications that 
iPS cells are more prone to develop tumors than embryonic stem 
cells.36  It is necessary to conduct equivalency studies comparing 
iPS and embryonic stem cells in order to definitively answer 
 
 33.  Id. 
 34.  See Sergio Pistoi, Do We Still Need Human Embryonic Stem Cells?, INT’L SOC’Y 
STEM CELL RESEARCH (Oct. 1, 2010), http://www.isscr.org/public/briefings 
/human_embryonic_stem_cells.html (citing studies). 
 35.  Paul Knoepfler, Some Inconvenient Truths About iPS Cells, KNOEPFLER LAB 
STEM CELL BLOG (Dec. 12, 2010, 4:41 PM), http://www.ipscell.com/home.php 
?s=some-inconvenient-truths-about-ips-cells. There is also evidence that the 
regressed cells retain a ‚memory‛ of their original state.  Jose M. Polo et al., Cell 
Type of Origin Influences the Molecular and Functional Properties of Mouse Induced 
Pluripotent Stem Cells, 28 NATURE BIOTECHNOLOGY 848, 851 (2010). 
 36.  See Louise C. Laurent et al., Dynamic Changes in the Copy Number of 
Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs During 
Reprogramming and Time in Culture, 8 CELL STEM CELL 106, 106-08 (2011). 
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these questions, but in the meantime we simply don’t know 
whether cells created using iPS lines will function in an identical 
manner as cells created using hESC lines over long periods of 
time. 
Another consideration in the comparison of iPS cell lines 
and hESC lines is the cost associated with therapies.  The 
advantage of iPS cell lines is that they are derived using the 
patient’s own somatic cells, and therefore avoid the need for 
immunosuppressant drugs.37  However, the disadvantage to the 
individualized iPS approach is that there are no economies of 
scale.  Each patient needs to have a distinct iPS cell line created 
using their unique cells, and each cell line needs to be 
individually tested for efficacy and safety before it can be used 
for therapy.38  In addition to being expensive (one estimate 
places the cost of creating an individual iPS cell line suitable for 
therapeutic use at $100,000 or more), this process is also time 
consuming and may make it impracticable to use iPS cell lines to 
 
 37.  It is likely that at least some immunosuppression drugs are necessary in 
connection with therapies using embryonic stem cells.  This is because embryonic 
stem cells are derived from blastocysts created in vitro and not from the patient’s 
own cells.  However, the degree of immunosuppression required, and the ability of 
the human body to tolerate stem cells derived from a foreign source, will not be 
known until more clinical trials using embryonic stem cells are conducted. 
One possible method for resolving the immunosuppression issue is through the 
process of therapeutic cloning, also called Somatic Cell Nuclear Transfer (‚SCNT‛).  
This process creates a blastocyst by combining an unfertilized egg with a cell 
nucleus containing the DNA of the patient.  The egg is then given a charge of 
electric current to induce cell division and an embryonic stem cell line is then 
created through the normal process.  The result is to create a stem cell line that 
shares the patient’s DNA.  Therapeutic cloning is perhaps the most controversial 
form of stem cell research due to the fear, among some segments of the public, that 
the embryos created via this process would not be used for research but would 
rather will be implanted in a women’s uterus and brought to term (so-called 
‚reproductive cloning‛).  Supporters of hESC research typically favor a ban on 
reproductive cloning, but resist efforts to ban therapeutic cloning.  Under current 
guidelines at the National Institutes of Health (NIH), no federal dollars are 
available to fund research using stem cell lines derived through therapeutic cloning. 
See 107th Congress Stem Cell Research, NAT’ INSTS. HEALTH RES. STEM CELL RESEARCH, 
http://stemcells.nih.gov/policy/legislation/archive107.htm (last modified Feb. 18, 
2009). 
 38.  Paul Knoepfler, Not Ready For Prime Time: The Three Critical Challenges for 
IPS Cells, KNOEPFLER LAB STEM CELL BLOG (Oct. 27, 2010, 1:55 PM), 
http://www.ipscell.com/home.php?s=not-ready-for-prime-time-the-three-critical-
challenges-for-ips-cells. 
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treat fast moving diseases.39  In contrast, embryonic stem cell 
lines can be used to create ‚batches‛ of clinically tested and 
approved stem cells that would be available ‚off the shelf‛ at a 
lower per patient cost.  The clinical trial begun by the company 
Geron in the fall of 2010, to treat spinal cord injuries, uses a 
hESC-based drug that was created in this latter fashion.40 
Finally, direct re-programming, while promising, possesses 
many of the same disadvantages as adult stem cells and iPS 
cells.  The direct re-programming process is both expensive and 
time consuming as compared to the hESC process.  Similar to the 
case with iPS cell lines, relatively small amounts of replacement 
cells are produced by direct re-reprogramming, whereas large 
quantities of cells are needed for transplant therapies.  Finally, 
the long term behavior of cells created via direct re-
programming is unknown.  More study is necessary in order to 
determine the degree to which this type of cell shares the same 
worrisome characteristics as iPS cells, such as the retention of a 
‚memory‛ of its prior state or a tendency towards tumor 
formation. 
Taken in combination, the disadvantages of each particular 
type of stem cell research may be less significant than when 
viewed in isolation. It is quite possible that any ‚cure‛ that 
results from stem cell research may result from the use of a 
combination of the above approaches being employed to 
address different components of a single disease. It is also 
possible that therapies derived from adult stem cells may prove 
superior to treat certain diseases, while hESC-based therapies 
turn out to be the optimal means of treating a different class of 
diseases. 
The existence of the alternatives of adult stem cells, iPS cells 
and direct reprogramming do not render embryonic stem cell 
research unnecessary or obsolete.  The replacement cells created 
by these four different techniques are not identical.  At this point 
in time, researchers don’t know enough about iPS cells or about 
 
 39.  Id. 
 40.  Id. 
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cells created via direct reprogramming to know whether they 
are exactly equivalent to the hESC and adult cells that have been 
studied for a decade or more. The comparability and 
equivalency of these various types of cells will continue to 
remain unknown unless parallel experiments are conducted that 
compare their longevity and malleability.  Therefore, research on 
all four types of cells should continue. 
Moreover, there are substantial costs associated with the 
abandonment of hESC experiments that are already underway.  
Important knowledge is being gained every day that will be lost 
or delayed for decades if researchers abandon these ongoing 
projects.  It is striking that the advances that led to both the iPS 
and direct reprogramming breakthroughs were made by 
researchers applying knowledge obtained from the study of 
embryonic stem cell lines.  All four types of stem cell research 
are related, and all four contribute to a common base of 
knowledge that is mutually beneficial. 
In summary, there is no scientific rationale that argues in 
favor of giving preferential treatment to one type of stem cell 
research over another.  In light of the science’s rapid progress 
upon multiple fronts, it is simply premature to declare that any 
one form of stem cell research is more likely to lead to therapies 
or cures than another, or that any particular type of stem cell 
research is unworthy of public funding.  Arguments in favor of 
directing public funding towards one form of stem cell research 
and away from another are premised upon religious or political 
agendas.41 
 
 41.  See JOHN DANFORTH, FAITH AND POLITICS: HOW THE ‚MORAL VALUES‛ 
DEBATE DIVIDES AMERICA AND HOW TO MOVE FORWARD TOGETHER 93 (2006).  
Former Senator Danforth writes: 
Unlike the issue of abortion, where a fetus in the womb will, with the 
passage of time, become a breathing human being, these cells in a petri 
dish have no potential other than what scientists can do with them to find 
cures for diseases. Calling these blastocysts human life can only be 
understood as a statement of religious doctrine, and advancing legislation 
to protect them can only be understood as attempting to enforce religion 
by resorting to the criminal law. 
Id.  
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  RELIGIOUS AND ETHICAL PERSPECTIVES ON STEM CELL 
RESEARCH 
THE MORAL STATUS OF THE EMBRYO 
Different faith traditions have different beliefs regarding the 
moral status of the embryo.42  The Catholic perspective is the 
religious point of view that is perhaps the most strongly 
opposed to hESC.  Official Catholic doctrine holds that life 
begins at the moment that the sperm and egg unite, and that the 
human embryo is therefore a person entitled to the same rights 
and dignity as any other person.43  The destruction of an 
embryo, under this view, is the equivalent of the taking of a life.  
Catholic doctrine also opposes the creation of an embryo for 
purposes other than procreation, and is critical of embryos being 
used for research on the grounds that it treats human life as the 
mere means to an end. 
Protestant opposition to hESC research has come from the 
Southern Baptist Convention and from fundamentalist 
Protestant denominations.  These Christian churches emphasize 
a strict interpretation of biblical language, focusing on passages 
that suggest that God recognizes the pre-born.  In addition, these 
denominations emphasize that embryonic stem cell research is 
 
 42.   Although it is common in public debate to refer to the blastocyst as an 
‚embryo,‛ the technical meaning of the word ‚embryo‛ applies only to a blastocyst 
that has attached to the uterus and has subsequently developed a structure called 
the ‚primitive streak‛ which lays out the body plan of the developing fetus.  In the 
human body, the developing fetus reaches this stage approximately fourteen days 
after fertilization.  Prior to this point, it is more accurate to refer to the blastocyst as 
a ‚pre-embryo.‛  See EVE HEROLD, STEM CELL WARS: INSIDE STORIES FROM THE 
FRONTLINES 121-22 (2006).  However, despite the technical meaning of the word 
‚embryo,‛ commentators outside of the medical profession typically use the word 
‚embryo‛ to refer to the fertilized egg at every stage of its development subsequent 
to the union of sperm and egg.  The discussion in this section will employ the word 
‚embryo‛ as it is commonly used by the public rather than in its more limited 
technical meaning.   
 43.  Norman Ford, The Human Embryo as Person in Catholic Teaching, 1 THE 
NAT’L CATH. BIOETHICS Q. 155, 159-60 (2001). 
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incompatible with the Christian mandate to protect the most 
vulnerable members of society, a group which they believe 
includes the embryo.  The National Association of Evangelicals 
has issued the following policy statement explaining its 
opposition to embryonic stem cell research: 
All humans, male and female, are made in the image of 
God (Genesis 1:27) and, therefore, have intrinsic dignity 
that should be respected and honored.  Indeed, the 
breath of life in all human beings is a gift from God 
(Genesis 2:7) and thus inherently holy. The NAE has 
pledged to protect the sanctity of human life and to 
safeguard its nature.  Thus, the NAE opposes all 
human cloning, including cloning human embryos for 
laboratory experimentation, as well as discrimination 
based on genetic identities.  The NAE welcomes and 
supports medical research that uses stem cells from 
adult donors and other ethical avenues of research.44 
In contrast, many mainline Protestant denominations have 
issued statements in support of embryonic stem cell research.  
One of the basic tenets of the Protestant Reformation was the 
embrace of the family as the basic unit of society, and this has 
found expression in a more accepting attitude towards non-
procreative sexual relations between husband and wife than 
under Roman Catholicism.45  In the United States, many 
mainline Protestant denominations have accepted contraception 
and abortion as questions of child-bearing that are appropriately 
left to the individual conscience of the woman.46  These Christian 
denominations focus on implantation in the womb as a more 
significant event than fertilization in the formation of 
personhood; the development of the fetus is seen as a process 
whereby personhood is attained gradually. Protestant 
denominations that support embryonic stem cell research 
 
 44. Respecting Human Dignity in Biotechnology, NAT’L ASS’N OF EVANGELICALS 
(2009), http://www.nae.net/fthn/respecting-human-dignity-in-biotechnology.  
 45.  Gloria H. Albrecht, Contraception and Abortion Within Protestant Christianity, 
in SACRED RIGHTS: THE CASE FOR CONTRACEPTION AND ABORTION IN WORLD 
RELIGIONS 79, 89-91 (Daniel C. Maguire ed., 2003). 
 46.  Id. at 94-96. 
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include the Episcopal Church,47 the Presbyterian Church 
(USA),48 the United Church of Christ,49 United Methodist 
Church,50 and the Unitarian Universalist Association of 
Congregations.51 
Jewish scholars also have been supportive of embryonic 
stem cell research.  The traditions of Judaism recognize that 
personhood begins with the child’s birth, and not before.  
Therefore, Judaism does not accord the embryo a moral standing 
outside of the womb independent of the mother.52  All of the 
major Jewish denominations support medical research using 
hESC: Reform,53 Conservative,54 Orthodox,55 and the 
Reconstructionist Rabbinical Association.56  In addition, Islamic 
scholars have been supportive of embryonic stem cell research 
when it is conducted for purposes of curing disease.57 
 
 47.  Episcopal Church, Resolution 2003-A014: Support Human Embryonic Stem 
Cell Research, THE ARCHIVES OF THE EPISCOPAL CHURCH (2003), 
http://www.episcopalarchives.org/cgi-bin/acts/acts_resolution.pl?resolution=2003-
A014. 
 48.  Presbyterians Vote in Favor of Fetal, Embryonic, and Stem Cell Research, 
SCIENCE BLOG (2001), www.scienceblog.com/community/older/2001 
/D/200114185.html. 
 49.  Twenty-Third Synod of the United Church of Christ, Support for Federally 
Funded Research of Embryonic Stem Cells, UNITED CHURCH OF CHRIST (2001), 
http://www.ucc.org/synod/resolutions/SUPPORT-FOR-FEDERALLY-FUNDED-
RESEARCH-ON-EMBRYONIC-STEM-CELLS.pdf. 
 50.  Ethics of Embryonic Stem Cell Research, THE UNITED METHODIST CHURCH 
(2004), http://archives.umc.org/interior.asp?ptid=4&mid=6560. 
 51.  Pass the Stem Cell Research Enhancement Act, UNITARIAN UNIVERSALIST 
ASS’N OF CONGREGATIONS, http://www.uua.org/socialjustice/socialjustice/ 
statements/8064.shtml (last updated June 3, 2010). 
 52.  See Yoel Jakobovits, Judaism and Stem Cell Research, TORAH.ORG (2002), 
http://www.torah.org/features/secondlook/stemcell.html. 
 53.  Urge the Senate to Support Stem Cell Research and Save Lives,  RELIGIOUS 
ACTION CTR. OF REFORM JUDAISM, http://rac.org/advocacy/issues/stemcell/#rjm (last 
updated July 26, 2005). 
 54.  Stem Cell Research and Education, THE UNITED SYNAGOGUE OF 
CONSERVATIVE JUDAISM  (2003), http://www.uscj.org/Stem_Cell_Research 
_a6675.html. 
 55.   Union of Orthodox Jewish Congregations Welcomes U.S. House Passage of Stem 
Cell Research Enhancement Act, ORTHODOX UNION INST. FOR PUB. AFFAIRS (May 25, 
2005), http://www.ou.org/public/statements/2005/n11.htm. 
 56.  Resolution on Educational and Political Support of Stem Cell Research, 
RECONSTRUCTIONIST RABBINICAL ASS’N (March 15, 2005), 
http://www.therra.org/members/conv2005/Res-StemCell-2005.pdf. 
 57.  Muzammil Siddiqi, An Islamic Perspective on Stem Cells Research, ISLAM101, 
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Other faith traditions have taken no official position either 
in favor of or against embryonic stem cell research.  Religious 
faiths that have not expressed an official position include the 
Church of Jesus Christ of Latter Day Saints,58 Hinduism59, and 
the American Baptist Churches.60 
 THE CALL TO HEAL THE SICK 
In addition to the moral status of the embryo, there is a 
separate faith tradition that is implicated by stem cell research.  
Many religious denominations teach that society has an 
affirmative obligation to heal the sick and to comfort those 
afflicted with disease.  For example, the Jewish faith includes a 
calling to pursue medical research as an affirmative duty, one 
that is often cited by Jewish supporters of stem cell research.  In 
addition, the more ‚liberal‛ Protestant denominations 
traditionally have embraced the benefits of scientific progress, 
and have accepted human reason and new discoveries as a force 
for good in the world.61 Persons from these Christian 
denominations who express support for embryonic stem cell 
research often point to Jesus’ miracles in healing the sick, and 
call on mankind to follow Jesus’ example. 
Bioethicist Laurie Zoloth has summarized the challenge 
presented by these alternative moral perspectives on medical 
research: 
I argue that the free inquiry of research science can be 
understood as a sort of free speech.  It is protected by 
the larger social polity, and it has to be responsive to 
 
http://www.islam101.com/science/stemCells.htm (last visited March 14, 2011). 
 58. Embryonic Stem-Cell Research, THE CHURCH OF JESUS CHRIST OF LATTER-DAY 
SAINTS, http://beta-newsroom.lds.org/official-statement/embryonic-stem-cell-
research (last visited March 14, 2011). 
 59.  Pankaj Mishra, How India Reconciles Hindu Values and Biotech, N.Y. TIMES, 
Aug. 21, 2005, at WK4.    
 60.  See generally Religious Groups’ Official Positions on Stem Cell Research, THE 
PEW FORUM ON RELIGION & PUB. LIFE (July 17, 2008), http://pewforum.org 
/Science-and-Bioethics/Religious-Groups-Official-Positions-on-Stem-Cell-
Research.aspx. 
 61.  See Albrecht, supra note 45, at 84. 
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the larger civic discourse, and to the meaning of the 
moral gesture of medicine.  If medicine’s future lies in 
genetics knowledge, how will such terrain shape our 
view of the self? If medicine’s future lies in 
transgression of boundaries understood as natural, 
how will we reconstruct a robust sense of morality and 
of a connection to the narrative past? 
 We live in the world as we find it, but medicine is, in 
a sense, about the world as we imagine it could be.  The 
task of the next century in medicine will be a complex 
and difficult freedom, for with emerging, 
transformative powers will come serious and vexing 
challenges.  Creating a duty-based response in research 
as well as in medicine will be needed if the calling at 
the heart of medicine continues to guide the work of 
the physician. . . . . 
 Different faith traditions—Buddhist, Hindu, Sikh, 
Muslim, and Jewish as well as Christian sensibilities—
will need to be considered now, and in most of these, 
the duty to heal the sick and the need for free scientific 
inquiry will be the primary considerations in this work.  
For many whose religion now prohibits any use of the 
early embryo, no matter how it is created, much of this 
research will be impermissible.  But others will argue 
that this opens the door to a critical research direction.  
Each member of the clergy and each lawmaker must 
think: how do we balance the many competing moral 
appeals?62 
Much of the controversy surrounding stem cell research can 
be traced to the existence of distinctive moral perspectives 
among persons of different faith traditions. 
 GUIDELINES FOR ETHICAL RESEARCH 
Because stem cell research uses human tissue, it raises many 
of the same ethical issues involved in any other type of medical 
research involving humans.  Most, if not all, research institutions 
have adopted guidelines to ensure that embryonic stem cell 
research progresses in an ethical manner.  For example, before 
 
 62.  Laurie Zoloth, Living Under the Fallen Sky: Science and Religion Meet 
Naturally, if Uneasily, in Healing, 36 HARV.  DIVINITY BULL. (Spring 2008), available at 
http://www.hds.harvard.edu/news/bulletin_mag/articles/36-2/zoloth.html. 
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engaging in embryonic stem cell research, scientists at the 
University of Wisconsin entered into contracts with the donors 
of blastocysts created for in vitro fertilization purposes, in order 
to establish a system of informed consent.63  These contracts also 
provided that only blastocysts that had previously been frozen 
would be made available for research and that no financial 
compensation would be paid to the donors.64 In addition, 
researchers at the University of Wisconsin sought and received 
approval from the university’s twenty-four person institutional 
review board, which concluded that the research could be 
conducted ethically after reviewing the work of national review 
boards in both the United Kingdom and Canada, as well as the 
report of the NIH’s Human Embryo Research Panel.65 
Since 2005, the National Academies of Sciences has 
maintained guidelines that call on all research institutions 
conducting embryonic stem cell research to establish a 
committee charged with Embryonic Stem Cell Research 
Oversight (ESCRO).66  The ESCRO Committee would be charged 
with the oversight of all issues related to the derivation and use 
of embryonic stem cells.  The current guidelines also call for 
institutions to document the provenance of stem cell lines 
utilized for research in order to verify that they were obtained 
with informed consent,67 and to prohibit any payment to the 
donors of blastocysts beyond direct expenses.68  In addition, the 
guidelines state that no embryonic stem cell research should be 
conducted that involves the use of blastocysts beyond the 
 
 63.  See Sanjay Jain & Gerard George, Technology Transfer Offices as Institutional 
Entrepreneurs: The Case of Wisconsin Alumni Research Foundation and Human 
Embryonic Stem Cells, 16 INDUS. & CORP. CHANGE 535, 546 (2007). 
 64.  Id. 
 65.  Id. at 545.  
 66. HUMAN EMBRYONIC STEM CELL RESEARCH ADVISORY COMMITTEE, NAT’L 
RESEARCH COUNCIL AND INST. OF MED. OF THE NAT’L ACADS., 2008 AMENDMENTS 
TO THE NATIONAL ACADEMIES’ GUIDELINES FOR HUMAN EMBRYONIC CELL 
RESEARCH, Appendix A Guideline 2.0 (2008), available at 
http://books.nap.edu/openbook.php?record_id=12260&page=21#p20015de59970021
001. 
 67.  Id. at Guideline 3.6. 
 68.  Id. at Guideline 3.4.  
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fourteenth day of development, or after the formation of the 
primitive streak, whichever occurs first.69 
In July 2009, the NIH adopted new guidelines that state 
which embryonic stem cell lines currently are eligible to receive 
federal funding. The NIH guidelines largely parallel the 
National Academies of Sciences recommendations on the issues 
of informed consent and the prohibition of compensation.  
However, under the current NIH guidelines, federal funding is 
limited to hESC lines derived from blastocysts created for 
purposes of in vitro fertilization.70 
THE CURRENT FUNDING LANDSCAPE 
Depending upon one’s perspective, the current funding 
landscape for stem cell research in the United States can either 
be applauded as an experiment in federalism or else decried as 
having caused the balkanization of medical research.  Currently, 
funding for stem cell research is provided in various forms and 
in various amounts by the federal government (through the 
NIH), by several state governments, and by private actors such 
as philanthropic foundations and investors in biomedical 
companies.  This funding landscape has developed over time, 
not due to any plan or conscious design, but rather as a result of 
the fact that ‚[f]or the past thirty years the political branches 
have been locked in a stalemate on the issue.‛71 
A BRIEF HISTORY OF FEDERAL FUNDING 
A brief summary of the history of federal funding of 
embryonic stem cell research is helpful at this point.  The 1993 
National Institutes of Health Revitalization Act removed legal 
 
 69.  Id. at Guideline 4.5. 
 70. Raynard S. Kingston, 2009 Guidelines on Human Stem Cell Research, THE 
NAT’L INSTS. OF HEALTH,  http://stemcells.nih.gov/policy/2009guidelines.htm 
 (last visited April 4, 2011).  For an analysis of the current NIH guidelines, see Wise 
Young, Analysis of 2009 NIH Human Stem Cell Research Policy, WISE 
YOUNG@CARECURE (July 9, 2009), http://wiseyoung.wordpress.com/2009/07/15/287/. 
 71.  Snead, supra note 1, at 1545. 
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impediments that had previously prevented the NIH from 
awarding federal funds to support research using human 
embryos.72  In September 1994, the NIH Human Embryo Panel, 
responding to a charge from President Clinton, issued a report 
recommending that some areas of human pre-embryo research 
receive federal funding, and making no distinction between 
excess blastocysts created during the in vitro fertilization process 
and blastocysts created expressly for research.73 President 
Clinton, however, directed the NIH not to allocate any resources 
that supported the creation of blastocysts expressly for research 
purposes.74 
However, before any regulations were adopted authorizing 
the federal funding of stem cell research, Congress passed the 
Dickey-Wicker Amendment.  Attached as a rider to an omnibus 
appropriations bill, and signed into law by President Clinton, 
the Dickey-Wicker Amendment prohibits the use of federal 
funds for the creation of a ‚human embryo‛ for research 
purposes or for research ‚in which a human embryo or 
embryos‛ are destroyed.75  The Dickey-Wicker Amendment has 
been reauthorized every year subsequent and is currently in 
force. 
In 1998, the Department of Health and Human Services 
issued an interpretation of the Dickey-Wicker Amendment 
concluding that the law did not prohibit the federal funding of 
research using stem cell lines that were derived from blastocysts 
that had been previously destroyed using private funding.76  
However, the Clinton Administration came to an end before any 
federal funds were allocated to support embryonic stem cell 
research under this interpretation.  President Bush agreed with 
the Clinton Administration’s interpretation of the Dickey-Wicker 
Amendment, however, and under his administration the NIH 
 
 72.  Id. 
 73.  Id. at 1546. 
 74.  Id. 
 75.  Id. 
 76.  Id. at 1546-47. 
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awarded federal funds to support embryonic stem cell research 
for the first time.77  However, President Bush directed that the 
only embryonic stem cell lines eligible to receive federal funding 
would be those that were already in existence on August 9, 2001, 
the date on which his policy was announced.78  The reason for 
this limitation was to ensure that federal funding did not create 
incentives for the ‚further destruction of human embryos.‛79  As 
the months passed after President Bush announced his policy, it 
became apparent that only twenty-one embryonic stem cell lines 
were both suitable for research purposes and eligible to receive 
federal funding.80 
On two separate occasions, Congress passed legislation that 
would have broadened federal funding of embryonic stem cell 
research to allow research using any blastocyst that was created 
during the in vitro fertilization process and that had been 
donated for research purposes with informed consent, but on 
both occasions Congress failed to override President Bush’s 
veto.81  The Bush Administration guidelines remained in place 
from 2001 until March 9, 2009 when they were rescinded by 
President Obama.82 
In July of 2009, the NIH issued new guidelines that 
permitted the use of federal funds for embryonic stem cell 
research so long as the blastocyst had been originally created for 
reproductive purposes and were donated with informed 
consent.83  The new NIH guidelines do not permit federal funds 
to be used for research that involves therapeutic cloning.  In 
 
 77.  Id. at 1550. 
 78.  Id. 
 79.  President George W. Bush, Announcement to Allow Federal Funding for 
Research on Existing Stem Cell Lines (Aug. 9, 2001) (transcript available at 
http://www.speakout.com/activism/apstories/10048-1.html). 
 80.  Snead, supra note 1, at 1550. 
 81.  Id. at 1551. 
 82.  See President Barack Obama, Remarks Prepared for Delivery Signing of 
Stem Cell Executive Order and Scientific Integrity Presidential Memorandum  
(March 9, 2009) (transcript available at http://www.whitehouse.gov 
/the_press_office/Remarks-of-the-President-As-Prepared-for-Delivery-Signing-of-
Stem-Cell-Executive-Order-and-Scientific-Integrity-Presidential-Memorandum/).  
 83.  Snead, supra note 1, at 1552-53. 
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promulgating the new NIH guidelines, the Obama 
Administration joined the Clinton and Bush Administrations in 
interpreting the Dickey-Wicker Amendment to allow such 
funding. 
ANALYSIS OF CURRENT FEDERAL AND STATE FUNDING 
ALLOCATION 
Currently, the federal funding of embryonic stem cell 
research lags well behind federal funding for alternative 
methods of stem cell research.  The Fiscal Year 2010 budget for 
the NIH allocated $126 million to hESC research, and it is 
estimated that $125 million will be allocated to embryonic stem 
cell research by the end of Fiscal Year 2011.84  The current 
estimate of hESC funding in the Fiscal Year 2012 NIH budget is 
approximately $128 million.85  In contrast, the Fiscal Year 2010 
budget for the NIH allocated $341 million for non-embryonic 
forms of human stem cell research, and it is estimated that the 
Fiscal Year 2011 NIH budget will fund non-embryonic research 
in an equal amount.86 In addition, funding of non-human 
(animal) stem cell research in Fiscal Year 2010 equaled $745 
million, and it is expected that in Fiscal Year 2011 the NIH will 
fund research using non-human (animal) stem cells in the 
amount of $744 million.87  In summary, between 2007 and 2010 
the NIH budget has never allocated more than 11% of the annual 
research budget for stem cell research to hESC research.  This 
trend is set to continue in 2011 when hESC research will 
constitute a mere $125 million out of a total budget of $1.098 
billion.88 
Federal funding of embryonic stem cell research is also 
being outpaced by state funding.  Between December 2005 and 
 
 84.  Nat’l Insts. Health Research Portfolio Online Reporting Tools, Estimates of 
Funding for Various Research, Condition, and Disease Categories, U.S. DEP’T OF HEALTH 
& HUMAN SERVS. (Feb. 14, 2011), http://report.nih.gov/rcdc/categories/. 
 85.  Id. 
 86.  Id. 
 87.  Id. 
 88.  Id. 
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the end of 2009, six states89 awarded a total of $1.25 billion in 
grants to support all types of stem cell research.90 Within the 
individual states, funding priorities vary among adult, 
embryonic, or iPS research.  A full 75% of California’s grants 
went to support hESC research, as did 97% of Connecticut’s 
grants.91  In contrast, New York only awarded 21% of its grants 
to support hESC research, with the bulk of its research dollars 
awarded for the study of iPS cells.92  Maryland and Illinois have 
funded a varied mix of adult and hESC research.93  Among 
them, these six states governments – and not the federal 
government – have provided the majority of research dollars 
spent on hESC research.94 
While some private foundations, such as the Juvenile 
Diabetes Research Foundation, are known to be significant 
funders of embryonic stem cell research, there is no national 
data that reveals the total amount of private dollars spent on 
stem cell research or that identifies the allocation of those dollars 
among hESC, adult or iPS cells. Philanthropic funding can 
shrink during economic downturns, and it is unknown what 
impact the recent recession has had on research funding by 
private foundations. Some experts predict that for-profit 
corporate funding will become an increasingly significant 
contributor to the funding of stem cell research, due to the 
uncertainties of philanthropic and government funding.95  
However, close ties between medical researchers and for-profit 
biotech companies raise their own distinct concerns.  Some fear 
that an increased reliance on corporate funding means that 
 
 89.  These states are California, Connecticut, Illinois, Maryland, New Jersey, 
and New York.  Ruchir N. Karmali et al., Tracking and Assessing the Rise of State-
Funded Stem Cell Research, 28 NATURE BIOTECHNOLOGY 1246, 1247 tbl.1 (Dec. 2010). 
 90.  Id. at 1246. 
 91.  Id. at 1247 tbl.1. 
 92.  Id. 
 93.  Id.  
 94.  Id. at 1247 (noting that state funding of hESC research on a cumulative 
basis from 2005 through 2009 exceeded NIH funding for hESC research during the 
same period). 
 95.  See Jessica Reaves, Stem Cell Research Skirts Hurdles, but Raises Ethics Issues, 
Too, N.Y. TIMES, Oct. 22, 2010, at A23.   
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financial results will dictate the course of research, rather than 
purely scientific considerations.96 
It appears unlikely that the traditional paradigm of the 
National Institutes of Health serving as the single funding 
mechanism for basic medical research will ever be attained in 
the case of stem cell research.  Despite the efforts of the Obama 
Administration to expand the types of stem cell lines that are 
eligible to receive federal funding, future congressional 
restrictions and future legal challenges to administrative 
rulemaking will almost certainly continue, and any hope of an 
uninterrupted stream of NIH funding is slim. In such an 
environment, it is doubtful that states will abandon their parallel 
funding schemes, while other alternatives to federal funding, 
such as state-private funding partnerships, will be explored. 
While it is unfeasible to dismantle state funding schemes for 
stem cell research at this time, it is nonetheless worth examining 
the reasons why a unified federal funding scheme administered 
through the NIH is the preferred mechanism for funding 
medical research.  First of all, unified funding through the NIH 
promotes an allocation of resources that directs research dollars 
to the most meritorious projects.  This is because channeling 
grant requests through a single funder allows that funder to use 
uniform application guidelines and a rigorous peer review 
process in order to select the most promising projects. It is 
inefficient for individual states to replicate this administrative 
infrastructure, and, by splitting the application pool among 
multiple funding sources, it is also possible that worthy 
applications will fall through the cracks. 
Another advantage of federal funding of medical research is 
that it promotes collaboration among researchers nationwide.  
The NIH can impose uniform guidelines and ethical standards 
concerning the derivation, donation, and cultivation of stem cell 
lines.  By creating a set of research data where all projects 
comply with the same standards, researchers can more easily 
 
 96.  Id. 
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share their data and compare results.  In addition, collaboration 
is more easily fostered by a single nationwide funder, both 
because the NIH can give preference to joint projects and 
because state boundaries need not constrain where the funds are 
spent. 
The expected high demand among the public to participate 
in clinical trials for stem cell therapies provides another reason 
to prefer channeling research funding through the NIH.  State 
funded clinical trials are likely give priority to state residents, 
given that state tax dollars were used to fund the underlying 
research.  However, patients outside of the funding state might 
be superior candidates to participate in a clinical trial.  A federal 
funding scheme ensures that only medical criteria are used to 
determine access to clinical trials. 
In addition, the federal government is in the best position to 
ensure transparency, so that the public is fully informed about 
what researchers are doing. By accepting federal dollars, 
research institutions agree to comply with the NIH’s ethical 
guidelines and to report on their activities.  In contrast, state 
funded research operates outside of any federal oversight, and, 
while California researchers operate under extensive state 
guidelines, other states employ varying degrees of supervision 
over the use of state dollars.97 Meanwhile, privately funded 
research occurs without any government oversight at all.  The 
use of federal funding serves an important function both as a 
means of imposing ethical limits on the research and also in 
ensuring a level of public oversight.  Without federal funding, a 
greater percentage of this research will occur outside of the 
public eye. 
Finally, federal funding of research also helps to promote 
industry standards and practices that eventually will be adopted 
by for profit entities. An absence of federal funding is the 
 
 97.  See generally Lori P. Knowles, State-Sponsored Human Stem Cell Research: 
Regulatory Approaches and Standard Setting, in STATES AND STEM CELLS: A SYMPOSIUM 
ON THE POLICY AND ECONOMIC IMPLICATIONS OF STATE-FUNDED STEM CELL 
RESEARCH 75-111 (Aaron D. Levine ed., 2006). 
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equivalent of an absence of federal rules.  Already, overseas 
stem cell clinics are marketing their services to residents of the 
United States. The growth of ‚stem cell tourism‛ is of great 
concern, especially given the wild claims and unproven 
therapies that are being touted by many foreign companies.  At 
some point in the future, companies will team with scientists in 
order to offer stem cell based therapies to the public 
domestically. Without federal research grants and standards, 
practices in the field will be driven by market forces rather than 
government created guidelines. The infertility industry is an 
example of a medical specialty that has grown largely 
independent of federal funding and oversight throughout its 
history, leading bioethicist Arthur Caplan to refer to in vitro 
fertilization clinics as ‚the wild, wild west of medicine.‛98 
While the federal funding of medical research offers several 
advantages, a scheme that relies on multiple state funders 
presents several disadvantages. First, state funding sources 
typically impose legal restrictions that limit the use of state 
funds to research that is conducted within the state’s borders.  
For example, money granted to researchers by the California 
Institute of Regenerative Medicine must be spent in California.99  
These restrictions make it difficult for researchers in different 
states to collaborate with each other. 
Second, various forms of regulatory inconsistency are 
created where there are multiple funders of basic research, even 
beyond restrictions on the use of research dollars.100  Perhaps the 
 
 98.  Tamara Audi & Arlene Chang, Assembling the Global Baby, WALL ST. J., Dec. 
20, 2010, http://online.wsj.com/article/SB10001424052748703493504576007774 
155273928.html 
 99.  CALIFORNIA INST. FOR REGIONAL MEDICINE, CIRM GRANTS 
ADMINISTRATION POLICY FOR ACADEMIC AND NON-PROFIT INSTITUTIONS 13 (April 
28, 2009), http://www.cirm.ca.gov/files/Regulations/NPGAP_042809a.pdf (‚CIRM-
funded research must be conducted in California.‛).  Private funders of stem cell 
research, such as the Juvenile Diabetes Research Foundation, also place restrictions 
on the use of their funds.  
 100.  See generally Geoffrey Lomax & Susan Stayn, Similarities and Differences 
Among State Stem Cell Policies: Opportunities for Policymakers, Patients, and Researchers, 
7 MED. RES. L. & POL’Y REP. 695 (2008), reprinted in BUREAU OF NAT’L AFFAIRS INC., 4 
(2008).  
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most vexing inconsistencies involve intellectual property rights.  
For example, when universities and research institutions license 
patented technology that they have developed using private 
funds, these institutions will often assert the right to exercise 
control over any discoveries that result from the use of the 
patented technology.101  In patent law, this is called a ‚reach 
through,‛102 and critics assert that the aggressive assertion of 
patent rights on basic scientific methods can chill future research 
that seeks to build on the prior discoveries. 
The NIH has used its influence as a funder of embryonic 
stem cell research to address concerns over ‚reach through‛ 
patent rights.  The patent rights to the methods used to isolate 
human embryonic stem cell lines are owned by the Wisconsin 
Alumni Research Foundation (WARF).  Many scientists objected 
to the license agreements by which WARF originally made 
embryonic stem cell lines available to researchers around the 
country, on the grounds that the agreements contained a 
provision retaining ‚reach through‛ rights for WARF covering 
any commercial applications developed by licensees.  The NIH 
and WARF were able to negotiate an agreement that clarified the 
extent and timing of any ‚reach through‛ rights in cases where 
stem cell research is funded by the federal government.  The 
existence of this agreement largely satisfied the concerns of 
researchers.103  However, state funding regimes create additional 
 
 101.  U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-03-536, TECHNOLOGY TRANSFER: 
AGENCIES’ RIGHTS TO FEDERALLY SPONSORED BIOMEDICAL INVENTIONS 3, 4 (2003), 
available at  http://www.gao.gov/new.items/d03536.pdf. 
 102.  See generally, Stephen G. Kunin et al., Reach-Through Claims in the Age of 
Biotechnology, 51 AM. U. L. REV. 609, 618 (2002).  
 103.   In 2001, WARF negotiated a Memorandum of Understanding with the 
NIH that permits academic researchers to have broad access to hESC for 
‚upstream‛ research while preserving WARF’s interest in ‚downstream‛ 
commercial applications.  See Rebecca S. Eisenberg & Arti K. Rai, Proprietary 
Considerations, 1 HANDBOOK OF STEM CELLS 793, 793 (2004); see also Jain, supra note 
63, at 548.   
In general, the NIH utilizes a Resource Sharing Plan that gives researchers an 
incentive to waive certain intellectual property rights in exchange for receiving 
federal funding.  See Office of Extramural Research, NIH Data Sharing Policy and 
Implementation Guidance, U.S. DEP’T OF HEALTH & HUMAN SERVS.,  
http://grants2.nih.gov/grants/policy/data_sharing/data_sharing_guidance.htm (last 
updated March 5, 2003). 
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and perhaps conflicting rules that govern the exercise of ‚reach 
through‛ rights in the context of research funded by the states 
rather than by the federal government.104  It is unclear whether 
the existence of inconsistent state rules regarding intellectual 
property rights has had a detrimental effect on the progress of 
embryonic stem cell research to date, but it is indisputable that 
the legal rights attached to new discoveries are more likely to 
promote innovation when they are uniform and predictable 
rather than conflicting and uncertain.105 
There are also indications that the balkanized funding 
landscape itself has influenced the types of stem cell research 
that have received government funding.  First of all, evidence 
shows that a substantial amount of hESC research currently 
being funded by the states would have qualified for federal 
funding even under the Bush administration’s 2001 NIH 
guidelines.106  This fact suggests that there is a greater demand 
for federal dollars to support embryonic stem cell research than 
the NIH has been able to satisfy.  It also suggests that the total 
amount of federal funding is insufficient even to support 
research using the original twenty-one hESC lines, much less to 
support research on all four types of stem cells.107 
Moreover, the funding data shows that the majority of those 
receiving state grants have not previously received NIH funding 
 
 104.  Owen Hughes, Pfizer, Remarks at the World Stem Cell Summit 2008 (Sept. 
23, 2008) (transcript available at http://worldstemcell08.blogspot.com 
/2008_09_01_archive.html  (speaking at the 2008 World Stem Cell Summit in 
Madison, Wisconsin, he stated:  
Nobody quite knows yet how it will play out . . . and it will get more 
complicated if the NIH decides to enter the funding arena.  The trigger 
points for the reach through events will be different for feds and states, 
and we don't clearly know what they are.).   
 105.  See generally Roger G. Noll, Designing an Effective Program of State-Sponsored 
Human Embryonic Stem Cell Research, 21 BERKELEY TECH. L. J. 1143, 1149-53  (2006).    
 106.  See Karmali, supra note 89, at 1247. 
 107.  On average, only twenty percent of applications for grants to support 
biomedical research receive NIH funding.  Nat’l Insts. of Health Research Portfolio 
Online Reporting Tools, Research Project Success Rates by NIH Institute for 2010, U.S. 
DEP’T OF HEALTH & HUMAN SERVS. http://report.nih.gov/award/success/Success 
_ByIC.cfm (Last updated Dec. 14, 2010). 
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for stem cell-related research.108  It appears that the existence of 
state funding schemes has drawn new researchers into the 
field.109  However, it is not clear that expanding the universe of 
grant recipients will necessarily lead to better research results, 
especially when scientists with more experience working with 
stem cells are struggling to obtain funding.  Those who receive 
state funds may not always have submitted the best research 
proposals.  Rather, a particular state may be funding mediocre 
proposals submitted by inexperienced researchers simply 
because those are the best applications received from a resident 
of that state. At the same time, experienced researchers are 
losing out on funding opportunities as a result of inadequate 
federal funding combined with simply being a resident in the 
wrong state. This geographic disparity in funding creates a 
strong incentive for scientists to relocate away from states that 
lack a funding mechanism and to move to states where a stable 
source of research funding is available.110 
LITIGATION AS A STRATEGY TO DISRUPT GOVERNMENT 
FUNDING 
Research projects involving embryonic stem cell lines require an 
uninterrupted stream of funding in order to succeed.  While the 
uncertain and changeable nature of governmental funding 
policies can impact this stream, funding is also vulnerable to 
disruption by non-governmental sources.  In two high profile 
instances, groups with religious objections to embryonic stem 
cell research have used litigation in an attempt to disrupt the 
 
 108.  See Karmali, supra note 89, at 1247. 
 109.  Id. 
 110.  See Aaron D. Levine, Research Policy and the Mobility of U.S. Stem Cell 
Scientists, 24 NATURE BIOTECHNOLOGY 865, 866 (2006) (concluding that stem cell 
scientists are more likely to receive job offers to move to new positions in states and 
foreign countries than are scientists in other biomedical fields, and stating that this 
data ‚lend*s+ credence to the claim that federal funding restrictions are negatively 
affecting the field’s development in the United States‛); see generally Aaron D. 
Levine, Policy Considerations for States Supporting Stem Cell Research: Evidence from a 
Survey of Stem Cell Scientists, 68 PUB. ADMIN. REV. 681 (2008).  
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financing of research.111 
 THE CALIFORNIA EXPERIENCE 
In November 2004, the voters of California approved a 
state-wide referendum to amend the state Constitution known 
as Proposition 71.  The terms of Proposition 71 authorized the 
state to issue $3 billion in general obligation bonds in order to 
support stem cell research.112  It also created the California 
Institute of Regenerative Medicine (CIRM) to serve as the vehicle 
for the award and supervision of research grants using this 
fund.113 
However, almost immediately after Proposition 71 was 
passed, a series of lawsuits were filed in California state courts 
seeking to prevent the state from issuing the bonds.  These 
lawsuits challenged the impartiality of the governing board of 
CIRM, alleged that the lack of state oversight over the operations 
of CIRM violated the California Constitution, and charged that 
the language of Proposition 71 violated the single subject 
requirement for state-wide initiatives.114  Funding for these 
lawsuits was provided by pro-life organizations seeking to 
overturn Proposition 71 or to delay its implementation for as 
long as possible.115  The ongoing litigation prevented California 
from issuing the bonds authorized by Proposition 71 for over 
two years, and bond sales did not occur until May 2007.116  In 
order to award research grants in the interim, CIRM was forced 
to borrow $45 million and obtain $150 million in bridge 
financing from the state treasury.117 The California Court of 
 
 111.  See Noll, supra note 105, at 1156-57. 
 112.  David Gollaher, The California Experiment, J. OF LIFE SCIENCES, Sept. 2007, at 
48, 50. 
 113.  Id. 
 114.  See Joel W. Adelson & Joanna K. Weinberg, The California Stem Cell 
Initiative: Persuasion, Politics, and Public Science, 100 AM. J. PUB. HEALTH 446, 448 
(2010). 
 115.  Id.; see also Gollaher, supra note 112, at 51.  
 116.  See Gollaher, supra note 112, at 51. 
 117.  Id. 
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Appeals ruled in CIRM’s favor in February 2007.118 
 SHERLEY V. SEBELIUS 
In August 2009, a lawsuit styled Sherley v. Sebelius119 was 
filed in federal district court challenging the NIH guidelines 
issued one month previously by the Obama administration.  
Among the named plaintiffs were two faith-based organizations.  
The plaintiffs argued that the July 2009 NIH guidelines, which 
expanded federal funding of hESC research beyond the twenty-
one lines approved under the prior guidelines, violated the 
Dickey-Wicker Amendment.  Judge Royce Lamberth granted the 
preliminary injunction sought by the plaintiffs, preventing the 
NIH from expending any federal funds until the completion of a 
trial on the merits. 
Judge Lamberth concluded that the language of the Dickey-
Wicker Amendment unambiguously prohibited the use of 
federal funds for research purposes if a blastocyst had been 
destroyed at any stage leading up to the federally funded 
portion of the research: 
The language of the statute does not support 
defendants’ alternative definition of research as ‘a piece 
of research.’  Indeed, the Dickey-Wicker Amendment 
does not contain any language to support such a 
limited definition of research.  Rather, the language of 
the statute reflects the unambiguous intent of Congress 
to enact a broad prohibition of funding research in 
which a human embryo is destroyed.  This prohibition 
encompasses all ‘research in which’ an embryo is 
destroyed, not just the ‘piece of research’ in which the 
embryo is destroyed.  Had Congress intended to limit 
the Dickey-Wicker to only those discrete acts that result 
in the destruction of an embryo, like the derivation of 
ESCs, or to research on the embryo itself, Congress 
 
 118.  Cal. Family Bioethics Council v. Cal. Inst. for Regenerative Med., 55 Cal. 
Rptr. 3d 272, 312 (Cal. Ct. App. 2007).   
 119.  Shirley v. Sebelius, 704 F. Supp.2d 63, 66 (D.D.C. 2010), vacated by No. 10-
5287, 2011 U.S. App. LEXIS 8686 (D.C. Cir. April 29, 2011). 
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could have written the statute that way.120 
Judge Lamberth also ruled that that the destruction of 
human embryos necessarily occurs when embryonic stem cell 
lines are created, thereby triggering the prohibition of the 
Dickey-Wicker Amendment: 
ESC research is clearly research in which an embryo is 
destroyed. To conduct ESC research, ESCs must be 
derived from an embryo.  The process of deriving ESCs 
from an embryo results in the destruction of the 
embryo.  Thus, ESC research necessarily depends upon 
the destruction of a human embryo.121 
Therefore, Judge Lamberth granted the motion for a preliminary 
injunction. 
Judge Lamberth’s ruling can be criticized on several fronts.  
First of all, his interpretation of the ‚unambiguous‛ language of 
the Dickey-Wicker Amendment is contrary to the interpretation 
adopted by three separate presidential administrations. This 
suggests that the contrary interpretation is at least a permissible 
reading of the statutory language and that therefore the federal 
courts should defer to the agency interpretation.  Second, under 
Judge Lamberth’s interpretation of the Dickey-Wicker 
Amendment, even the Bush administration’s 2001 funding 
guidelines are unlawful. At no time during the Bush 
administration did Congress express such understanding of the 
law.  Finally, by granting a preliminary injunction, Judge 
Lamberth necessarily found that the plaintiffs would suffer 
irreparable harm if the NIH guidelines were not immediately 
enjoined.122  However, as discussed above, there is absolutely no 
evidence that the availability of federal funds for embryonic 
stem cell research has limited or detracted from the availability 
of funds for research using adult stem cells or iPS cells. The 
federal government currently funds far more research using 
 
 120.  Shirley, 704 F. Supp.2d at 70-71. 
 121.  Id. at 71. 
 122.  Id. at 72  (Judge Lamberth held as follows: ‚The guidelines, by allowing 
federal funding of ESC research, increases [sic] competition for NIH's limited 
resources. This increased competition for limited funds is an actual, imminent 
injury.‛).   
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adult stem cells than embryonic stem cells, and to date the 
primary financial support for embryonic stem cell research has 
come from state governments.   
In other words, the plaintiffs did not demonstrate a 
likelihood of success on the merits of their claim, nor could they 
show that they were likely to suffer irreparable harm in the 
absence of a preliminary injunction halting the future funding of 
embryonic stem cell research. The United States Court of 
Appeals for the District of Columbia Circuit held as much on 
April 29, 2011, when it vacated Judge Lamberth’s order granting 
the preliminary injunction.123  The litigation remains ongoing as 
this article goes to press. 
The decision of the Court of Appeals allows the National 
Institutes of Health to continue funding embryonic stem cell 
research for the time being.  However, while the Circuit Court 
expressed skepticism over the plaintiffs’ interpretation of the 
Dickey-Wicker Amendment, it is still possible that Judge 
Lamberth will rule for the plaintiffs on the merits of the case.  
Future appeals are likely in either event, perhaps all the way to 
the United States Supreme Court.  The uncertainty generated by 
legal challenges to state and federal funding of embryonic stem 
research has had a measurable negative impact on the 
development of stem cell science.124 
THE NEED FOR NEUTRAL PRINCIPLES TO GUIDE MEDICAL 
RESEARCH 
As the foregoing discussion illustrates, the rapid progress of 
scientific knowledge concerning human stem cells, as well as 
religious and political considerations, have worked in 
combination to influence the funding landscape for stem cell 
research.  The result, whether intended or not, has been to turn 
 
   123.    Sherley v. Sebelius, No. 10-5287, 2011 U.S. App. LEXIS 8686, at *30 (D.C. 
Cir. April 29, 2011). 
 124.  See generally Aaron D. Levine, Policy Uncertainty and the Conduct of Stem Cell 
Research, 8 CELL STEM CELL 132 (2011). 
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the method of funding medical research into a force that 
impedes progress. The seeds were sown when the Bush 
administration decided in 2001 to limit federal funding to 
twenty-one pre-existing hESC lines, thereby creating a de facto 
incentive for scientists to develop an over reliance on a limited 
subset of hESC lines. Now, in 2010, researchers who have 
devoted years to working with these specific hESC lines are 
understandingly hesitant to abandon this knowledge base in 
order to pursue iPS research or cell reprogramming research.  
Nor is it obvious that our society is better off if scientists cease 
studying hESC lines, since future progress in the entire field will 
benefit from the knowledge gained concerning embryonic stem 
cell lines. 
It is not surprising that individual states have sought to fill 
the gap in available federal funding by acting strategically and 
focusing on funding a narrow range of stem cell research.  It is 
logical to use specialization as a means of seeking the maximum 
impact from limited dollars, because state governments lack the 
resources of the federal government. Thus, California has 
become a center of embryonic stem cell research while New 
York has taken the lead in funding research using iPS cells.125 
However, as states compete against each other for researchers, 
seeking to attract top talent to relocate within their borders, the 
current funding landscape creates an incentive to build off of 
their existing subject area strengths rather than to seek a wide 
variety of talent.  The sorting of research focus among different 
geographic areas will result in an entrepreneurial and 
competitive market, where each state has an economic incentive 
to pursue their chosen type of research and where private 
companies will sort themselves geographically to parallel each 
 
 125.  For example, the Empire State Stem Cell Board has awarded over $16 
million in funds targeted to iPS and other non-embryonic derivation approaches to 
stem cells. See Stem Cell Research Award Grantees, NEW YORK STATE DEP’T OF 
HEALTH, http://www.nyhealth.gov/funding/targeted_and_generic_award_list.htm 
(last revised March 2009).  In New York, twenty-one percent of research grants have 
gone to support hESC while in California fully seventy-five percent of research 
grants have supported hESC research.  See Karmali, supra note 89, at Table 1. 
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state’s specialization.126  This self-selection process feeds on 
itself, and it is unlikely to reverse even if NIH funding continues. 
Therefore, the current balkanized funding landscape is not 
the optimum approach towards advancing stem cell science.  In 
particular, the current funding scheme is inferior to the 
alternative of using the NIH as a single source of funding for all 
types of stem cell research.  However, now that several states 
have invested in the facilities and other infrastructure involved 
in setting up a funding mechanism separate from the NIH, it is 
doubtful that these states will walk away from that investment.  
It is too late to turn back the clock and attempt to re-centralize 
funding at the federal level. 
In an attempt to avoid the recurrence of similar funding 
controversies in the future, some observers have suggested 
placing the decision of whether to federally fund different kinds 
of medical research exclusively in the hands of medical 
researchers, thereby isolating these decisions from political 
influence.127  However, this approach has been criticized on the 
grounds that it fails to ensure democratic accountability and that 
it effectively abandons ethical principles.128 In any event, it is 
manifestly unrealistic to assume that politicians at either level—
state or federal—will relinquish their power to influence the 
determination of public health policy. 
The recognition that politicians have primacy of place in the 
field of public bioethics is not the end of the matter, however.  
While it may be useful to underscore the fundamental role that 
our elected officials play in the determination of stem cell 
funding policy, this observation does not lead to the conclusion 
that these officials should be left with unbounded discretion.  To 
the contrary, when fulfilling their responsibility to formulate 
funding policies for medical research, our elected 
representatives should be guided by two objective and neutral 
principles: 1) the federal government should be the preferred 
 
 126.  See Noll, supra note 105, at 1169-70. 
 127.  See Snead, supra note 1, at 1553-58. 
 128.  Id. at 1604. 
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source for funding basic medical research and 2) funding 
decisions should not adopt one religious perspective over 
another. 
THE FEDERAL GOVERNMENT SHOULD BE THE PREFERRED SOURCE 
OF FUNDING FOR BASIC MEDICAL RESEARCH 
The freedom of scientific inquiry was one of the key 
principles of the ‚American Enlightenment.‛129  Basic intellectual 
themes advanced during the founding of our nation included 
the right of free speech, the connection between an educated 
citizenry and the possibility of self-government, and the 
opposition to the Stamp Act on the grounds that it acted as an 
economic barrier to the free circulation of ideas.130  The Founders 
believed strongly in the value of ‚knowledge diffused 
generally‛ among the people.131  The belief that scientific inquiry 
was a force for the benefit for all mankind was popularly held, 
and found its embodiment in the persona of Benjamin 
Franklin.132 Any restrictions on scientific progress, whether 
imposed by governmental or clerical sources of authority, were 
resisted strenuously.  It is significant that the limited universe of 
powers granted to the federal government under the 
Constitution included the power to create a system for issuing 
patents.  The federal government created by the United States 
Constitution was vested with its power by a people who 
believed that public benefits flowed inevitably from creativity in 
the sciences and the useful arts.133 
Support for medical research is consistent with this 
traditional vision of the power of the federal government, 
despite objections that have been raised concerning federal 
regulation of the broader health care market.  The question has 
 
 129.  Id. at 1560-63. 
 130.  See LEWIS HYDE, COMMON AS AIR: REVOLUTION, ART, AND OWNERSHIP 93-
100 (2010). 
 131.  See id. at 95 (quoting John Adams). 
 132.  See id. at 112-34. 
 133.  See GORDON S. WOOD, THE RADICALISM OF THE AMERICAN REVOLUTION 
191-92 (1991). 
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arisen whether the federal government possesses the power 
under the Commerce Clause of the Constitution to mandate the 
purchase of private health insurance.  Opponents of health care 
reform argue that the Commerce Clause should be read to 
circumscribe the power of the federal government to intervene 
in the private market for health care insurance, often citing the 
economist Friedrich Hayek in support of their views.  However, 
Hayek’s caution against government overreaching in private 
markets does not apply to the funding of basic research,134 and 
Hayek himself was a strong supporter of free scientific 
inquiry.135 
Instead, the funding of stem cell research is best understood 
as a modern manifestation of the federal government’s 
traditional use of general tax revenues to invest in industries 
that contribute to the national infrastructure and that therefore 
benefit the entire nation. Government support for new 
technologies in the transportation and communication industries 
 
 134.  As explained by Hayek: 
All modern governments have made provision for the indigent, 
unfortunate, and disabled and have concerned themselves with questions 
of health and the dissemination of knowledge. . .  . There are common 
needs that can be satisfied only by collective action and which can be thus 
provided for without restricting individual liberty. . . . There is little reason 
why the government should not also play some role, or even take the 
initiative, in such areas as social insurance and education, or temporarily 
subsidize certain experimental developments. 
FRIEDRICH A. HAYEK, THE CONSTITUTION OF LIBERTY 257-58 (1960) (emphasis 
added). 
 135.  Id. at 404-05.  Hayek wrote generally in support of scientific progress and 
against government interference in the free dissemination of knowledge: 
Personally, I find that the most objectionable feature of the conservative 
attitude is its propensity to reject well-substantiated new knowledge 
because it dislikes some of the consequences which seem to follow from it . 
. . .  I will not deny that scientists as much as others are given to fads and 
fashions and that we have much reason to be cautious in accepting the 
conclusions that they draw from their latest theories.  But the reasons for 
our reluctance must themselves be rational and must be kept separate 
from our regret that the new theories upset our cherished beliefs.  I can 
have little patience with those who oppose, for instance, the theory of 
evolution or what are called ‘mechanistic’ explanations of the phenomena 
of life simply because of certain moral consequences which at first seem to 
follow from these theories, and still less with those who regard it as 
irreverent or impious to ask certain questions at all. 
Id. 
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has long been accepted as a means of promoting economic 
development. However, in the 21st century our nation’s 
economic growth is not driven by industries that produce and 
ship tangible products.  Instead, the fastest growing sectors of 
the American economy are tied to intellectual advances in areas 
such as biotechnology and telecommunications. The state of 
California promoted its bond offering to fund the creation of 
CIRM as a state investment in ‚intellectual capital.‛136 In so 
doing, California officials drew a parallel between government 
investment in intellectual infrastructure in the sciences and the 
traditional government financial support of physical 
infrastructure such as roads and bridges. 
The present universe of scientific knowledge is not static, 
and the federal government plays an important role in funding 
efforts to expand upon our current base of knowledge. The 
federal government has greater resources than state 
governments, it can generate greater economies of scale when 
allocating research dollars among recipients, and, when it serves 
as the primary source of research funding, the federal 
government can avoid needless duplication of research efforts. 
The role of the federal government is critical because it is 
highly unlikely that the private market will fund the optimum 
amount of basic medical research from a societal perspective.  
Private industry is beholden to its shareholders, who demand a 
return on their investment.  This profit motive risks the creation 
of ‚orphan diseases,‛ instances where companies forego 
research that is unlikely to lead to profitable applications due to 
the small number of persons afflicted.  Shareholders also possess 
a short investment horizon, which creates a disincentive for 
management to fund research where direct applications lie 
decades in the future.137 The federal government does not 
 
 136.  See Treasurer Lockyer Urges Californians to Participate in First Stem Cell Bond 
Issue: $250 Million Sale Makes State Leader in Embryonic Stem Cell Research, CAL.  INST. 
FOR REGIONAL MED. (Oct. 2, 2007), www.cirm.ca.gov/PressRelease_100207. 
 137.  See Melissa Little et al., Delivering on the Promise of Human Stem-Cell 
Research: What Are the Real Barriers?, 7 EUR. MOLECULAR BIOLOGY ORG. REP. 1188, 
1190-91 (2006) (listing as impediments to private investment in the field skepticism 
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operate within these constraints. 
Without government funding, the pharmaceutical and 
biotechnology industries will only serve the interests of those 
with the most common afflictions, or the interests of those who 
can afford expensive drugs and therapies. Low-income 
populations, in particular, are vulnerable to being left out of a 
market-driven system of medical research.  In such cases, the 
federal government should use its funding power to help ensure 
that vital research continues and that the benefits of such 
research are made available to all. 
FUNDING DECISIONS SHOULD NOT ADOPT ONE RELIGIOUS 
PERSPECTIVE OVER ANOTHER 
Government policymakers must base their public health 
decisions on non-religious grounds.  The federal government 
should not incorporate one particular religious point of view as 
part of the official rationale for deciding whether or not to fund 
medical research.  To do so is to adopt one religious perspective 
over another.  There are a variety of religious perspectives on the 
moral status of the embryo, and it would violate the 
Constitution for any branch of government to endorse one 
religious perspective on the issue over another.138 
A respect for religious pluralism is one of the basic tenets of 
 
over ‚the likely success of stem-cell research,‛ the fear that consumers will associate 
the company with a controversial topic, uncertainty over intellectual property 
rights, a lack of experience with the FDA approval process in the context of stem 
cells and doubts that any marketable products will ultimately result from the 
science). 
 138.  John Danforth, the former Republican Senator from Missouri and an 
ordained Episcopal priest, concluded as much: 
What distinguishes the opposition to embryonic stem cell research and 
[therapeutic cloning] is that it is based solely on a religious belief that life 
begins before implantation in the uterus.  This religious concept is in 
opposition to the convictions of other people of faith who do not share this 
definition of the beginning of life, and who believe that it is their own 
religious obligation to discover the cures for disease, to heal the sick, to 
relieve suffering, and to save lives. 
Legislators considering banning such research should realize that they are 
being asked to establish one religious point of view and to oppose another. 
DANFORTH, supra note 41, at 97. 
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our constitutional system.  It is well understood that the First 
Amendment of the Constitution precludes the federal 
government from establishing an official religion.139  However, 
there is also strong evidence that the original language that 
James Madison proposed for the First Amendment was intended 
to go further and disestablish official religions at the state level 
as well.140  Significantly, the First Amendment was designed to 
protect freedom of conscience by preventing any one religious 
sect from receiving a preferential place under the law.141  In fact, 
the overall purpose of the First Amendment to the Constitution 
was to ensure that all religious faiths were treated in a non-
preferential fashion by public officials. 
One example of the Founders’ concern over government 
acts that granted preferential treatment to one religious 
denomination over another is reflected in the early debate over 
the constitutionality of the executive branch issuing prayer day 
proclamations.  While Presidents Washington and Adams had 
issued proclamations declaring a ‚national day of prayer,‛ 
President Jefferson considered such proclamations 
unconstitutional under the First Amendment.142  James Madison 
agreed with Jefferson, explaining his opposition on the grounds 
that the public trust that is delegated to elected officials does not 
include the agency to decide questions of religious faith.143 
These basic principles continue to carry great weight today.  
Recent Supreme Court precedent has employed the doctrine of 
judicial review in order to police the separation of church and 
state.  The Court has emphasized that under the Constitution all 
official government acts must have a rational basis beyond the 
government’s desire to adopt a moral point of view.  In order to 
 
 139.  WILLS, supra note 8, at 226-29.  
 140.  Id. at 229-32.  The language of the First Amendment that was ultimately 
ratified did not directly speak to this point, and states would continue to support 
established religions with tax dollars until Massachusetts abandoned the practice in 
1833.  See also DANIEL WALKER HOWE, WHAT HATH GOD WROUGHT: THE 
TRANSFORMATION OF AMERICA, 1815-1848 164-65 (2007).   
 141.  See WILLS, supra note 8, at 232-35. 
 142.  Id. at 237. 
 143.  Id. at 237-41. 
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establish rational grounds for passing legislation, for example, 
state legislators cannot rely solely on moral arguments that 
condemn sodomy.144 The Supreme Court also struck down a 
popularly ratified amendment to the Colorado State 
Constitution on the grounds that it could only be defended as an 
expression of animus against homosexuals that was premised 
upon moral condemnation.145  If, as expected, the Ninth Circuit 
rules that California’s prohibition on same sex marriage violates 
the Constitution, it will be one consequence of the federal courts’ 
refusal to sanction official government policies that rest solely on 
religious justifications.146 
It has been argued that the government’s refusal to accord 
blastocysts donated for research the moral status of a ‚person‛ 
would itself be a choice that promotes a religious perspective.  
This argument mistakenly assumes that the federal government 
is being asked to choose between a religious perspective and a 
secular perspective, and that to choose secularism is the 
equivalent of choosing a religious point of view.  As discussed 
above, the stem cell funding debate does not ask the government 
to make a binary choice between, on the one hand, advancing 
religion or advancing secularism on the other.  Instead, the 
government is being asked to choose among a variety of 
different religious perspectives that view the beginning of 
personhood as occurring at different stages.  For the government 
 
 144.  See Lawrence v. Texas, 539 U.S. 558, 578 (2003) (Kennedy, J.) (holding that 
the Texas anti-sodomy statute ‚furthers no legitimate state interest which can 
justify its intrusion into the personal and private life of the individual‛).  In the 
same case, Justice O’Connor stated:  
Moral disapproval of this group, like a bare desire to harm the group, is an 
interest that is insufficient to satisfy rational basis review under the Equal 
Protection Clause . . . .  Indeed, we have never held that moral 
disapproval, without any other asserted state interest, is a sufficient 
rationale under the Equal Protection Clause to justify a law that 
discriminates among groups of persons. 
Id. at 582 (O’Connor, J., concurring). 
 145.  See Romer v. Evans, 517 U.S. 620, 634 (1996). 
 146.  See Perry v. Schwarzenegger, 704 F. Supp. 2d 921, 1001 (N.D. Cal. 2010), 
cert. denied, 130 S. Ct. 2432 (stating that the ‚evidence shows conclusively that moral 
and religious views form the only basis for a belief that same-sex couples are 
different from opposite-sex couples‛). 
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to remain neutral among these choices is not the same as the 
government endorsing one perspective over another.  
Government decisions that impact the funding of medical 
research must be justifiable upon non-religious grounds. 
 CONCLUSION 
Professor O. Carter Snead has argued persuasively that, in 
questions of public bioethics, publicly accountable elected 
officials should be called to make the hard policy decisions 
themselves rather than to delegate their decision-making 
authority to panels of scientific experts.147  However, what is 
missing from Professor Snead’s analysis is the recognition that 
these elected officials exercise a public trust.  The defect in 
Professor Snead’s approach to public bioethics is that it 
emphasizes the ‚bioethics‛ component of the term at the 
expense of the ‚public‛ component.  When making policy 
decisions in the realm of public health, politicians must be able 
to justify their choices on the basis of objective and neutral 
principles. 
The study of public bioethics is incomplete without a 
recognition that the federal government operates within a 
sphere of authority and under an obligation of pluralism that is 
separate from the spheres of religion and the market economy.148  
Within its proper sphere, the federal government has an 
affirmative responsibility to foster the pursuit of knowledge, and 
it lacks the capacity to adopt as its own one out of a competing 
multitude of religious viewpoints.  The Madisonian separation 
of church and state is an integral part of the limited government 
created under the United States Constitution,149 and maintaining 
that separation is an ethical good that our elected officials must 
 
 147.  See Snead, supra note 1, at 1602. 
 148.  See generally MICHAEL WALZER, SPHERES OF JUSTICE: A DEFENSE OF 
PLURALISM AND EQUALITY 243-48 (1983) (Walzer argues that a free society consists 
of separate spheres within which the state, the church, and corporations each 
dominate, and where the polity acts to maintain the separation of the spheres.). 
 149.  See generally WILLS, supra note 8, at 175-249 (tracing the intellectual 
foundations of the separation of church and state under the Constitution). 
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weigh along with other ethical goods such as the protection of 
vulnerable populations and the promotion of justice. 
The convergence of science, religion and politics in the 
determination of public health policy presents a recurring 
temptation for policymakers to adopt policies designed to curry 
favor with distinct religious denominations rather than policies 
based upon scientific and medical objectives.  This danger is 
heightened when the ever-changing state of scientific knowledge 
allows elected officials to exploit uncertainties and conflicting 
data when expressing the rationale for their position. 
The federal government’s slow response to the AIDS crisis 
in the 1980s reflects one manifestation of this phenomenon.  
Today, a common refrain among scientists engaged in stem cell 
research is that the uncertain availability of federal funds for 
hESC research over the past decade has slowed progress 
towards translating basic science into cures, has deterred 
graduate students and other researchers from entering the entire 
field, and has jeopardized the United States’ leadership position 
in stem cell research versus our global competitors.150  If the stem 
cell funding controversy provides any lessons for the future, it is 
that the failure to follow objective and neutral principles when 
making decisions for the public good inevitably undermines the 
achievement of our society’s objectives to extend lives and to 
reduce suffering. 
 
 
 150.  See Public Funding Impacts Progress of Human Embryonic Stem Cell Research, 
SCIENCE DAILY (June 5, 2008), http://www.sciencedaily.com/releases/2008/06 
/080604140945.htm. 
